Key result
A critical evaluation of citalopram indicates that while it can cause QTc prolongation, overdoses do not demonstrate clinically meaningful differences in cardiotoxic effects versus other antidepressants.
Why the study?
Does citalopram cause clinically significant cardiac toxicity or QT prolongation compared to other antidepressants?
Does citalopram cause clinically significant cardiac toxicity or QT prolongation compared to other antidepressants?
This review challenges the clinical significance of the FDA warning regarding citalopram-induced QT prolongation, suggesting its cardiotoxicity in standard use and overdose is comparable to other antidepressants.
No takes yet. Share an insight, caveat, or question.
Questions citalopram-specific QTc precautions in practice; challenges FDA warnings but leaves open prospective confirmation.
Robert H. Howland (2011) conducted a review in Citalopram cardiac toxicity. Citalopram vs. Other antidepressants was evaluated on QTc prolongation and cardiotoxic effects. A critical evaluation of citalopram indicates that while it can cause QTc prolongation, overdoses do not demonstrate clinically meaningful differences in cardiotoxic effects versus other antidepressants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: